Clinical Characteristics and Surgical Outcomes of Low-grade Epilepsy-associated Brain Tumors

Overview

Journal Ther Adv Neurol Disord

Specialty Neurology

Date 2024 Mar 25

PMID 38525487

Authors

Suhui Kuang

Shaohui Zhang

Zhiqiang Cui

Ming Ge

Liu Yuan

Jiaqi Wang

Zhirong Wei

Jinshan Xu

Feng Zhai

Shuli Liang

Affiliations

Soon will be listed here.

Abstract

Background: Low-grade epilepsy-associated brain tumors (LEATs) are found to be the second most common lesion-related epilepsy. Malignant potential of LEATs is very low and the overall survival is good, so the focus of treatment is focused more on seizure outcome rather than oncological prognosis.

Objectives: This study was conducted to evaluate the risk factors of seizure outcomes after resection in patients with LEATs.

Design: A retrospective study.

Methods: A retrospective analysis of patients with LEATs who underwent resective surgery in our three epilepsy centers between October 2010 and April 2023 with a minimum follow-up of 1 year. Demography, clinical characters, neurophysiology, and molecular neuropathology were assessed for association with postoperative seizure outcomes at 1-, 2-, and 5-year follow-up. Synthetic minority oversampling technique (SMOTE) algorithm model was performed to handle the imbalance of data distribution. Gaussian Naïve Bayes (GNB) algorithms were created as a basis for classifying outcomes according to observation indicators.

Results: A total of 111 patients were enrolled in the cohort. The most common pathology was ganglioglioma ( = 37, 33.3%). The percentage of patients with seizure freedom was 91.0% (101/111) at 1-year follow-up, 87.5% (77/88) at 2-year follow-up, and 79.1% (53/67) at 5-year follow-up. Partial resection had a significantly poor seizure outcome compared to total resection and supratotal resection ( < 0.05). The epileptiform discharge on post-resective intraoperative electrocorticography (ECoG) or postoperative scalp electroencephalography (EEG) were negative factors on postoperative seizure freedom at 1-, 2-, or 5-year follow-ups ( < 0.05). The area under the receiver-operating characteristic curve value of the GNB-SMOTE model was 0.95 (95% CI, 0.876-1.000), 0.892 (95% CI, 0.656-0.934), and 0.786 (95% CI, 0.491-0.937) at 1-, 2-, and 5-year follow-up, respectively.

Conclusion: The partial resection, post-resective intraoperative ECoG, and postoperative scalp EEG were valuable indicators of poor seizure outcomes. The utilization of post-resective intraoperative ECoG is beneficial to improve seizure outcomes. Based on the data diversity and completeness of three medical centers, a multivariate correlation analysis model was established based on GNB algorithm.

References

Lopez-Rivera J, Smuk V, Leu C, Nasr G, Vegh D, Stefanski A . Incidence and prevalence of major epilepsy-associated brain lesions. Epilepsy Behav Rep. 2022; 18:100527. PMC: 8885987. DOI: 10.1016/j.ebr.2022.100527. View

Griffis J, Allendorfer J, Szaflarski J . Voxel-based Gaussian naïve Bayes classification of ischemic stroke lesions in individual T1-weighted MRI scans. J Neurosci Methods. 2015; 257:97-108. PMC: 4662880. DOI: 10.1016/j.jneumeth.2015.09.019. View

Du N, Shu W, Li K, Deng Y, Xu X, Ye Y . An initial study on the predictive value using multiple MRI characteristics for Ki-67 labeling index in glioma. J Transl Med. 2023; 21(1):119. PMC: 9922464. DOI: 10.1186/s12967-023-03950-w. View

Seidel S, Wehner T, Miller D, Wellmer J, Schlegel U, Gronheit W . Brain tumor related epilepsy: pathophysiological approaches and rational management of antiseizure medication. Neurol Res Pract. 2022; 4(1):45. PMC: 9442934. DOI: 10.1186/s42466-022-00205-9. View

Yuan Y, Xiang W, Yanhui L, Ruofei L, Shuang L, Yingjun F . Ki-67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control. Seizure. 2013; 22(10):877-81. DOI: 10.1016/j.seizure.2013.08.004. View

Zweiphenning W, van t Klooster M, van Klink N, Leijten F, Ferrier C, Gebbink T . Intraoperative electrocorticography using high-frequency oscillations or spikes to tailor epilepsy surgery in the Netherlands (the HFO trial): a randomised, single-blind, adaptive non-inferiority trial. Lancet Neurol. 2022; 21(11):982-993. PMC: 9579052. DOI: 10.1016/S1474-4422(22)00311-8. View

Santos-Pinheiro F, Park M, Liu D, Kwong L, Cruz S, Levine N . Seizure burden pre- and postresection of low-grade gliomas as a predictor of tumor progression in low-grade gliomas. Neurooncol Pract. 2019; 6(3):209-217. PMC: 6656314. DOI: 10.1093/nop/npy022. View

Liubinas S, DAbaco G, Moffat B, Gonzales M, Feleppa F, Nowell C . IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas. Epilepsia. 2014; 55(9):1438-43. DOI: 10.1111/epi.12662. View

Lange F, Hornschemeyer J, Hornschemeyer M, Kirschstein T . Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy. Cells. 2021; 10(5). PMC: 8156732. DOI: 10.3390/cells10051226. View

10.

Aronica E, Specchio N, Luinenburg M, Curatolo P . Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy. Brain. 2023; 146(7):2694-2710. PMC: 10316778. DOI: 10.1093/brain/awad048. View

11.

Zhu Q, Liang Y, Fan Z, Liu Y, Zhou C, Zhang H . The utility of intraoperative ECoG in tumor-related epilepsy: Systematic review. Clin Neurol Neurosurg. 2021; 212:107054. DOI: 10.1016/j.clineuro.2021.107054. View

12.

Slegers R, Blumcke I . Low-grade developmental and epilepsy associated brain tumors: a critical update 2020. Acta Neuropathol Commun. 2020; 8(1):27. PMC: 7063704. DOI: 10.1186/s40478-020-00904-x. View

13.

van Breemen M, Wilms E, Vecht C . Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007; 6(5):421-30. DOI: 10.1016/S1474-4422(07)70103-5. View

14.

Mann C, Conradi N, Neuhaus E, Konczalla J, Freiman T, Spyrantis A . Early Epilepsy Surgery in Benign Cerebral Tumors: Avoid Your 'Low-Grade' Becoming a 'Long-Term' Epilepsy-Associated Tumor. J Clin Med. 2022; 11(19). PMC: 9571257. DOI: 10.3390/jcm11195892. View

15.

Mittal S, Barkmeier D, Hua J, Pai D, Fuerst D, Basha M . Intracranial EEG analysis in tumor-related epilepsy: Evidence of distant epileptic abnormalities. Clin Neurophysiol. 2015; 127(1):238-244. DOI: 10.1016/j.clinph.2015.06.028. View

16.

van Klink N, Zweiphenning W, Ferrier C, Gosselaar P, Miller K, Aronica E . Can we use intraoperative high-frequency oscillations to guide tumor-related epilepsy surgery?. Epilepsia. 2021; 62(4):997-1004. PMC: 8248094. DOI: 10.1111/epi.16845. View

17.

Faramand A, Barnes N, Harrison S, Gunny R, Jacques T, Tahir M . Seizure and cognitive outcomes after resection of glioneuronal tumors in children. Epilepsia. 2017; 59(1):170-178. DOI: 10.1111/epi.13961. View

18.

Kerkhof M, Benit C, Duran-Pena A, Vecht C . Seizures in oligodendroglial tumors. CNS Oncol. 2015; 4(5):347-56. PMC: 6082346. DOI: 10.2217/cns.15.29. View

19.

Ko A, Lee J . Factors associated with seizure and cognitive outcomes after epilepsy surgery for low-grade epilepsy-associated neuroepithelial tumors in children. Clin Exp Pediatr. 2020; 63(5):171-177. PMC: 7254172. DOI: 10.3345/kjp.2019.01151. View

20.

Yao P, Zheng S, Wang F, Kang D, Lin Y . Surgery guided with intraoperative electrocorticography in patients with low-grade glioma and refractory seizures. J Neurosurg. 2017; 128(3):840-845. DOI: 10.3171/2016.11.JNS161296. View